type here...

CATEGORIES

Treatments

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

Medika Life -
TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

On the treatment of Covid-19

Medika Life -
Based on the available scientific evidence and current clinical experience, the SPR Collaboration recommends that physicians and authorities consider the following Covid-19 treatment protocol for the early treatment of people at high risk or high exposure

Eggshell-based surgical material for skull injuries

Medika Life -
A bioactive polymer-ceramic composite for fixing implants and restoring bone defects in the skull was developed by an international group of materials scientists

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston -
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories